Clinical Trials Sponsored by Sei Won Lee

Total 142 results

Sei Won Lee
Korea Centers for Disease Control & Prevention

Unknown

Impact of Particulate Matter in Chronic Obstructive Pulmonary Disease Patients

COPD
Lei Lei, MD

Recruiting

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. (ADHD)

Attention Deficit Disorder With Hyperactivity | Executive Function Disorder

China
Se-Hoon Lee

Terminated

AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)

SCLC, Recurrent

Korea, Republic of
Se-Hoon Lee

Unknown

Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy (LC_Biomarker)

Lung Cancer

Korea, Republic of
Se-Hoon Lee
AstraZeneca

Completed

Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects (SUKSES-N4)

Small Cell Lung Cancer

Korea, Republic of
Lei Du

Unknown

The Perioperative Risks of Adverse Events After Cardiac Surgery: a Retrospective Study (PRAECS)

Risks of Adverse Events After Cardiac Surgery

China
Yuanli Lei

Completed

Effects of Percutaneous Coronary Intervention in Patients With Cardiac Arrest After Acute Myocardial Infarction: a 2-Year Study

Acute Myocardial Infarction
Yuanli Lei

Completed

The Role of Electrocardiograms in Risk Stratification and Analysis of the Characteristics of ST Elevation in Acute Myocarditis: a 2-centre Study

Myocarditis

China
Xu Lei

Unknown

Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in China

Hypertension

China
General Public Hospital Zell am See

Unknown

Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD

Gastroesophageal Reflux Disease

Austria
General Public Hospital Zell am See

Completed

A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) | Extraesophageal Symptoms

Austria
General Public Hospital Zell am See

Completed

Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

Austria
General Public Hospital Zell am See

Completed

Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial

Gastroesophageal Reflux Disease | Laparoscopic Antireflux Surgery

Austria
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union

Femoral Shaft Fracture | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet Rich Plasma for Knee Osteoarthritis

Osteo Arthritis Knee | Platelet-rich Plasma

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Platelet-rich Plasma | Ankle Instability

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Meniscus Repair

Knee Injuries | Platelet-Rich Plasma | Meniscus Disorder

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head

Bone Marrow | Avascular Necrosis of Femur

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Rotator Cuff Tear

Rotator Cuff Tear | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Low Back Pain

Discogenic Pain | Platelet-rich Plasma

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery

Spinal Fusion | Bone Marrow

Taiwan
Lei ZHAO

Recruiting

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

Intrahepatic Cholangiocarcinoma

China
Lei Li

Recruiting

ctDNA Methylation for Detecting Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA Index

China
See Yourself Health LLC
University of Louisville

Not yet recruiting

The Hope App Study

Type 2 Diabetes

United States
Lei Li

Recruiting

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Chemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian Cancer

China
Lei Li

Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical Cancer

China
Lei Li

Recruiting

Prognosis of Low-grade Endometrial Stromal Sarcoma

Recurrence | Survival Outcomes | Adjuvant Therapy | Hormone Therapy | Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis) | Fertility-sparing Surgery | Fertility Outcomes

China
Lei Li

Recruiting

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Recurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1

China
Lei Li

Recruiting

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Chemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound Paclitaxel

China
Lei Li

Recruiting

Genetic Mutation in Recurrent Cervical Cancer

Microsatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1

China
Lei Li

Recruiting

Survival Outcomes of Uterine Malignancies in Chinese Population

Endometrial Neoplasms | Survival

China
Lei Li

Unknown

A Training Set for the HRD Model in EOC

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum Resistance

China
Lei Li

Unknown

Immunohistochemical Staining of p16 for the Screening of Cervical Cancer

Cervical Intraepithelial Neoplasia | Cervical Cancer Screening | Histology | p16 Protein | Cytology | High-risk Human Papillomavirus | Diagnostic Accuracy

China
Lei Li

Unknown

Cell-free DNA Methylation for Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Liquid Biopsy | DNA Methylation | Benign Ovarian Tumor | Training Set | Validation Set | Cell-free DNA

China
Lei Li

Unknown

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Chemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 Antibody

China
Lei Li

Unknown

Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese

China
Lei Li

Unknown

Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis

Endometrial Cancer | Adenomyosis | Genomics | Eutopic Endometrium | Transcriptomics | Ectopic Endometrial Tissue

China
Lei Li

Unknown

A Multi-omics Study of Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | Tumorigenesis

China
Lei Li

Unknown

Survival Outcomes of Ovarian Malignancies in Chinese Population

Ovarian Neoplasms | Survival

China
Lei Li

Unknown

Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

Uterine Cervical Neoplasms | Survival

China
Lei Li

Recruiting

HRD and Resistance to PAPPi in EOC Patients

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Homologous Recombination Repair Gene Mutation | Drug Resistance | Overall Survival | Progression-free Survival | Poly(ADP-ribose) Polymerase Inhibitor

China
Lei Li

Recruiting

Cervical Cancer Screening Strategies

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection | Cancer Screening | Cervical Cytology

China
Lei Li

Recruiting

Different Surgical Approaches in Patients of Early-stage Cervical Cancer

Quality of Life | Mortality | Pelvic Floor Disorders | Laparotomy | Laparoscopy | Cost-Benefit Analysis | Morbidity | Survival | Uterine Cervical Neoplasm

China
Lei Li

Recruiting

Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer

Recurrence | Uterine Cervical Neoplasms | Mortality | Laparotomy | Laparoscopy | Survival

China
Lei Jiang
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer

Lung Cancer | Video-Assisted Thoracic Surgery

China
Lei Jiang

Recruiting

Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS

Thoracic Surgery | Thoracic Neoplasm | Mediastinal Neoplasms

China
Lei Du

Active, not recruiting

Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

Glaucoma | Pterygium | Platelet-rich Fibrin | Macular Holes

China
Lei Li

Completed

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Chemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma

China
Lei Li

Completed

First-line Chemotherapy for Recurrent Cervical Cancer

Chemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 Inhibitor

China
Shen Lei

Completed

Chemoprophylaxis Plus Early Ambulation

Pulmonary Embolism | Thoracic Surgery

China

Clinical Trials Sponsored by Sei Won Lee

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations